News

• Gilead's revenues up 3% to $6.6B in Q1
  04/28/2022 / 22:04 - TeleTrader
•  
• Jyseleca® approved in Japan for ulcerative colitis
  03/28/2022 / 08:01 - GlobeNewswire
•  
• C4 Therapeutics Appoints Utpal Koppikar to Board of Directors
  03/16/2022 / 21:05 - GlobeNewswire
•  
• Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights
  03/14/2022 / 12:00 - GlobeNewswire
•  
• Gritstone Reports Fourth Quarter 2021 and Full Year 2021 Financial Results and Provides Corporate Updates
  03/10/2022 / 22:05 - GlobeNewswire
•  
• Gritstone Announces Three Presentations for Tumor-Specific Neoantigen (TSNA) Oncology Programs, GRANITE and SLATE, at the 2022 AACR Annual Meeting
  03/08/2022 / 23:15 - GlobeNewswire
•  
• Affinia Therapeutics Strengthens Leadership Team with Appointment of Diana M. Brainard, M.D., to the Board of Directors
  03/08/2022 / 13:30 - GlobeNewswire
•  
• Jounce Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
  03/02/2022 / 13:00 - GlobeNewswire
•  
• Biomea Fusion Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights
  02/28/2022 / 22:05 - GlobeNewswire
•  
• Jounce Therapeutics to Participate in Cowen & Co. 42nd Annual Health Care Conference
  02/28/2022 / 14:00 - GlobeNewswire
•  
• General Catalyst Names Stephen K. Klasko Executive-In-Residence
  02/25/2022 / 12:00 - GlobeNewswire
•  
• Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2021 Financial Results
  02/24/2022 / 22:05 - GlobeNewswire
•  
• Galapagos 2021 results set stage for future growth
  02/24/2022 / 22:01 - GlobeNewswire
•  
• Gritstone to Participate in Cowen 42nd Annual Health Care Conference
  02/24/2022 / 13:00 - GlobeNewswire
•  
• Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  02/08/2022 / 22:05 - GlobeNewswire